The growth of interventional oncology market is primarily driven by the rising preference for minimally invasive procedures, expansion of the target patient population, increasing public-private funding and government support for cancer research, technological advancements in the field of interventional oncology, and increasing government investments and funding for interventional oncology and related cancer research.
Interventional Oncology Market by Product (Radiofrequency, microwave, cryoablation, embolization, guidewires), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung, Kidney, Bone Metastasis).
The global interventional oncology market is projected to reach USD 2.9 billion by 2024 from USD 2.0 billion in 2019, at a CAGR of 6.8%.
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=203687164
The Global Interventional Oncology Market is Segmented on:
1. Product
2. Procedures
3. Cancer
4. Region
Product:
The embolization devices segment accounted for the largest share of the interventional oncology market in 2018. The large share of this segment can be attributed to the rising prevalence of cancer, product enhancements, and the increasing adoption of Yttrium-90 radioembolic agents in emerging countries.
Procedures:
In 2018, the TARE/SIRT procedures segment accounted for the largest market share majorly due to the rising prevalence of cancer, increasing demand for minimally invasive procedures, growing adoption of embolization procedures, and the clinical efficacy of Yttrium-90 radioembolic agents (which are used in these procedures).
Cancer:
The liver cancer segment accounted for the largest share of the interventional oncology market in 2018. The large share of this segment can be attributed to factors such as rising cases of liver cancer across the globe and growing initiatives/research activities for developing advanced liver cancer therapies using interventional oncology.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=203687164
Geographical Growth Analysis:
The Asia Pacific regional market is expected to grow at the highest CAGR during the forecast period. Emerging economies in the region such as India, China, and South Korea, along with developed markets such as Japan and Australia, are offering high-growth opportunities for market players in the field of interventional oncology. This can be attributed to factors such as the increasing adoption of interventional oncology procedures, growing incidence of cancer, and the growing geriatric population.
Interventional Oncology : Cancer Research Reshaping The Global Industry
Read this article to find out how you deal with cancer.Avoid eating sugary foods to prevent the growth of cancer cells growth.
There are several cancer treatments in existence, so consult with a doctor regularly.Be aware of the fruits and vegetables that you buy at the store.
Make it a frank and open dialogue on the subject.You can dramatically lower your chances of getting colon cancer by about 40% through regular physical activity.Many people do know that wild salmon is very healthy and delicious.These people include oncologists, chemo specialists, oncologists, or anyone who assists you, helps you or empathizes with your situation.
It will help if you let these people into your life to help.Be thankful for the support that you do receive.Always pay attention and stay involved in the situation.
People living with cancer need any love and positive energy from others they can get, so when people pity them, they tend to feel bad about themselves.Not all types of clothing are going to keep the harmful rays from reaching your skin.
If you cannot find any in your local stores, the Internet is an excellent resource for specialty retailers.
Get rid of your face cancer by having a consultation with Dr Mudit Agarwal and following his medication.
He holds more than 15 years of experience in oncology and has done many successful surgeries.
For more details visit headneckdoctor.com
Growth in this market is driven mainly by the rising prevalence of lymphoma & myeloma cancers, growing focus on personalized medicine, and increasing collaborations for developing assays.The services segment accounted for the largest share of the product & services segment in the hemato oncology testing market in 2018.Based on product & services, the market is segmented into assay kits and services.
In 2018, the services segment accounted for the largest share of the product & services segment in the hemato oncology testing market.
The large share of this segment can be attributed to the rising prevalence of hematologic cancers and increasing aging population.Download the PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=262472877Availability of robust infrastructure and high-end equipment for conducting hemato oncology tests are the supporting factors for clinical laboratories segmentBased on end-user, the hemato-oncology testing market has been segmented into four types, i.e., clinical laboratories, hospitals, academic & research institutes, and other end-users.
Other end-users include CROs and pharmaceutical & biotechnological companies.
Clinical laboratories accounted for the largest share of the market in 2018.
This segment is expected to grow at the highest rate in the coming years.
Read this article to find out how you deal with cancer.Avoid eating sugary foods to prevent the growth of cancer cells growth.
There are several cancer treatments in existence, so consult with a doctor regularly.Be aware of the fruits and vegetables that you buy at the store.
Make it a frank and open dialogue on the subject.You can dramatically lower your chances of getting colon cancer by about 40% through regular physical activity.Many people do know that wild salmon is very healthy and delicious.These people include oncologists, chemo specialists, oncologists, or anyone who assists you, helps you or empathizes with your situation.
It will help if you let these people into your life to help.Be thankful for the support that you do receive.Always pay attention and stay involved in the situation.
People living with cancer need any love and positive energy from others they can get, so when people pity them, they tend to feel bad about themselves.Not all types of clothing are going to keep the harmful rays from reaching your skin.
If you cannot find any in your local stores, the Internet is an excellent resource for specialty retailers.
Get rid of your face cancer by having a consultation with Dr Mudit Agarwal and following his medication.
He holds more than 15 years of experience in oncology and has done many successful surgeries.
For more details visit headneckdoctor.com
Growth in this market is driven mainly by the rising prevalence of lymphoma & myeloma cancers, growing focus on personalized medicine, and increasing collaborations for developing assays.The services segment accounted for the largest share of the product & services segment in the hemato oncology testing market in 2018.Based on product & services, the market is segmented into assay kits and services.
In 2018, the services segment accounted for the largest share of the product & services segment in the hemato oncology testing market.
The large share of this segment can be attributed to the rising prevalence of hematologic cancers and increasing aging population.Download the PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=262472877Availability of robust infrastructure and high-end equipment for conducting hemato oncology tests are the supporting factors for clinical laboratories segmentBased on end-user, the hemato-oncology testing market has been segmented into four types, i.e., clinical laboratories, hospitals, academic & research institutes, and other end-users.
Other end-users include CROs and pharmaceutical & biotechnological companies.
Clinical laboratories accounted for the largest share of the market in 2018.
This segment is expected to grow at the highest rate in the coming years.